Clinical Trial Update: Anti-psychotic Medication (New Use) Weight Loss Study [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a repurposed antipsychotic for obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Avera McKennan Hospital & University Health Center | Conditions: Obesity | Phase 2 | Status: WITHDRAWN